期刊文献+
共找到3篇文章
< 1 >
每页显示 20 50 100
Synergistic effect of interleukin-10-receptor variants in a case of early-onset ulcerative colitis 被引量:7
1
作者 Martina Galatola Erasmo Miele +9 位作者 Caterina Strisciuglio Lorella Paparo Daniela Rega Paolo Delrio Francesca Duraturo Massimo Martinelli Giovanni Battista Rossi Annamaria Staiano Paola Izzo Marina De Rosa 《World Journal of Gastroenterology》 SCIE CAS 2013年第46期8659-8670,共12页
AIM: To investigated the molecular cause of very early-onset ulcerative colitis (UC) in an 18-mo-old affected child.
关键词 Inflammatory bowel disease ulcerative colitis Interleukin 10 receptors Tumour necrosis factor α receptors Beta catenin
下载PDF
Effects of Modified Sanhuang Decoction (加味三黄汤) Enemaon Serum Tumor Necrosis Factor-α and Colonic Mucosa Interleukin-1β,Interleukin-6 Levels in Ulcerative Colitis Rats 被引量:8
2
作者 王帅 周滔 +2 位作者 翟军鹏 王丽华 陈誩 《Chinese Journal of Integrative Medicine》 SCIE CAS 2014年第11期865-869,共5页
Objective:To investigate the effects of Modified Sanhuang Decoction(加味三黄汤,MSD)enema on the serum tumor necrosis factor alpha(TNF-α)and colonic mucosa interleukin-1β(IL-1β),interleukin-6(IL-6)levels in... Objective:To investigate the effects of Modified Sanhuang Decoction(加味三黄汤,MSD)enema on the serum tumor necrosis factor alpha(TNF-α)and colonic mucosa interleukin-1β(IL-1β),interleukin-6(IL-6)levels in experimental ulcerative colitis(UC)rats.Methods:Forty-five male Wistar rats were randomly divided into 4 groups:normal group(n=12),model group(n=11),salazosulfapyridine(SASP)group(n=11)and MSD group(n=11).The UC model was induced by 2,4,6-trinitrobenzene sulfonic acid(TNBS)/ethanol solution.Rats in the normal group and model group were clystered with 0.9%normal saline,while in the SASP group and MSD group were clystered with SASP and MSD enema,respectively.After drug administration(10 mL/kg body weight,for 7 days),colonic gross changes and colonic mucosa histology were observed,serum TNF-αand colonic mucosa IL-1β,IL-6 levels were tested by enzyme linked immunosorbent assay and radioimmunoassay,respectively.Results:As compared with the normal group,the experimental UC rats,the colonic mucosal damage index scores(CMDIs),histopathological scores(HS)and the serum TNF-a and colonic mucosa IL-1β,IL-6 levels significantly increased(P〈0.05 or P〈0.01).In the MSD and SASP groups,the ulcer area significantly reduced,and edema disappeared.The CMDIs,HS,the serum TNF-a and colonic mucosa IL-1β,IL-6 levels in the MSD and SASP groups significantly decreased(P〈0.05 or P〈0.01)compared with the model group.The CMDIs in the MSD group were lower than that in the SASP group(P〈0.05),but there were no significant differences in HS,serum TNF-αor colonic mucosa IL-1β,IL-6 levels between the MSD and SASP groups.Conclusion:MSD enema can improve colonic mucosa impairment and decrease serum TNF-αand colonic mucosa IL-1β,IL-6 levels in experimental UC. 展开更多
关键词 ulcerative colitis Chinese herbal therapy tumor necrosis factor-α interleukin-1β interleukin-6
原文传递
Immunosuppressive therapies for inflammatory bowel disease 被引量:4
3
作者 Talia Zenlea Mark A Peppercorn 《World Journal of Gastroenterology》 SCIE CAS 2014年第12期3146-3152,共7页
Inflammatory bowel disease (IBD) is comprised of Crohn&#x02019;s disease and ulcerative colitis, both chronic inflammatory intestinal disorders of unknown etiology characterized by a waxing and waning clinical cou... Inflammatory bowel disease (IBD) is comprised of Crohn&#x02019;s disease and ulcerative colitis, both chronic inflammatory intestinal disorders of unknown etiology characterized by a waxing and waning clinical course. For many years, the drug therapy was limited to sulfasalazine and related aminosalicylates, corticosteroids and antibiotics. Studies suggesting that the pathophysiology of these disorders relates to a disregulated, over-active immune response to indigenous bacteria have led to the increasing importance of immunosuppressive drugs for the therapy of IBD. This review details the mechanisms of action, clinical efficacy, and adverse effects of these agents. 展开更多
关键词 Crohn’ s disease ulcerative colitis Inflammatory bowel disease Immunosuppressives Tumor necrosis factor inhibitors
下载PDF
上一页 1 下一页 到第
使用帮助 返回顶部